Copyright
©The Author(s) 2020.
World J Gastroenterol. Sep 21, 2020; 26(35): 5343-5353
Published online Sep 21, 2020. doi: 10.3748/wjg.v26.i35.5343
Published online Sep 21, 2020. doi: 10.3748/wjg.v26.i35.5343
Table 4 The lowest t-score in relation to anti-tumor necrosis factor-α therapy in both study groups
Groups | mean ± SD | 95%CI | P value | |
CD group | ||||
No anti-TNF-α | -1.10 ± 1.04 | -1.56 to -0.63 | 0.98 | |
Anti-TNF-α | -1.48 ± 1.23 | -1.88 to -1.09 | ||
UC group | ||||
No anti-TNF-α | -0.74 ± 1.11 | -1.25 to -0.22 | 0.185 | |
Anti-TNF-α | -1.10 ± 0.87 | -1.83 to -0.37 |
- Citation: Ewid M, Al Mutiri N, Al Omar K, Shamsan AN, Rathore AA, Saquib N, Salaas A, Al Sarraj O, Nasri Y, Attal A, Tawfiq A, Sherif H. Updated bone mineral density status in Saudi patients with inflammatory bowel disease. World J Gastroenterol 2020; 26(35): 5343-5353
- URL: https://www.wjgnet.com/1007-9327/full/v26/i35/5343.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i35.5343